Frederick Frank (May 31, 1932 – September 11, 2021) was an American banker, with more than 50 years of experience on Wall Street.

He is considered the first investment banker to have specialized in the areas of biotechnology, pharmaceuticals, and health care services.

He previously served as vice chairman of Lehman Brothers, Barclays Capital, and the Peter J. Solomon Company.

After completing the required formal training program, Frank joined the research department to work with Bill Grant on the pharmaceutical and chemical industries.

In 1962, he shifted focus to the life sciences industries, dealing with medical devices, diagnostics companies, and healthcare services.

Frank is credited with creating original and at times unprecedented structures that have connected innovative early-stage research-oriented companies with larger development and market-oriented pharmaceutical corporations.

[12] In 1978, Frank led a team at Lehman Brothers, handling Humana's acquisition of American Medicorp.

[20] As of October, 1997, the non-profit Tanner Frank Foundation of New York City was granted charitable status.

In 2007, he established a professorship,[11] which was first filled in 2009 when Gary Gorton became Yale's first Frederick Frank Class of 1954 Professor of Management and Finance.